These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17299983)

  • 21. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors determining the modality selection in dialysis].
    Kessler M; Chanliau J
    Nephrologie; 2000; 21(2):45-6. PubMed ID: 10798203
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progress in the therapy of chronic kidney failure in Japan: Dialysis and renal transplantation].
    Kawaguchi Y
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1460-70. PubMed ID: 12082736
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodialysis in Japan--present and future].
    Maekawa M
    Z Urol Nephrol; 1988 Feb; 81(2):111-8. PubMed ID: 3259357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modality selection of dialysis therapy for diabetic end-stage kidney disease].
    Hara S; Arizono K; Ogura Y; Mimura N
    Nihon Rinsho; 1992 Jan; 50 Suppl():177-85. PubMed ID: 1578674
    [No Abstract]   [Full Text] [Related]  

  • 26. Daily evaluation of organ function during renal replacement therapy in intensive care unit patients with acute renal failure.
    Cappi SB; Sakr Y; Vincent JL
    J Crit Care; 2006 Jun; 21(2):179-83. PubMed ID: 16769463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood purification in chronic renal failure with severe liver disease].
    Sudo M
    Nihon Rinsho; 1992 Jan; 50 Suppl():112-7. PubMed ID: 1578663
    [No Abstract]   [Full Text] [Related]  

  • 28. [Assessment of integrated replacement therapy in patients with terminal renal insufficiency: selection vs election].
    Lampreabe I; Muñiz ML; Zárraga S; Amenábar JJ; Erauzkin GG; Gómez-Ullate P; Gaínza FJ
    Nefrologia; 2001; 21 Suppl 5():4-13. PubMed ID: 11881412
    [No Abstract]   [Full Text] [Related]  

  • 29. Past, present and future of end-stage renal disease therapy in the United States.
    Uribarri J
    Mt Sinai J Med; 1999 Jan; 66(1):14-9. PubMed ID: 9989100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On-line filtration therapies: emerging horizons.
    Kooman JP; van der Sande FM; Beerenhout CM; Leunissen KM
    Blood Purif; 2006; 24(2):159-62. PubMed ID: 16340182
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous versus intermittent renal replacement therapy in the intensive care unit.
    Bellomo R; Ronco C
    Kidney Int Suppl; 1998 May; 66():S125-8. PubMed ID: 9573588
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of hypertension in dialysis patients and renal transplant recipients].
    Małyszko J; Fryc J; Myśliwiec M
    Przegl Lek; 2005; 62(7):694-7. PubMed ID: 16463704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal replacement therapy in the intensive care unit.
    Ghossein C; Grouper S; Soong W
    Int Anesthesiol Clin; 2009; 47(1):15-24. PubMed ID: 19131749
    [No Abstract]   [Full Text] [Related]  

  • 34. Continuous renal replacement therapy: evolution in technology and current nomenclature.
    Ronco C; Bellomo R
    Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. End-stage renal disease in patients with Fabry disease.
    Obrador GT; Ojo A; Thadhani R
    J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S144-6. PubMed ID: 12068027
    [No Abstract]   [Full Text] [Related]  

  • 36. Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe.
    Rutkowski B
    Nephrol Dial Transplant; 2006 Jan; 21(1):4-10. PubMed ID: 16280373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is renal replacement therapy for all possible in developing countries?
    Aviles-Gomez R; Luquin-Arellano VH; Garcia-Garcia G; Ibarra-Hernandez M; Briseño-Renteria G
    Ethn Dis; 2006; 16(2 Suppl 2):S2-70-2. PubMed ID: 16774015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Active treatment of renal disease in Finland].
    Stenman S; Grönhagen-Riska C
    Duodecim; 1995; 111(15):1497-504. PubMed ID: 9244706
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal replacement therapy in Nepal.
    Hirachan P; Kharel T; Shah DS; Ball J
    Hemodial Int; 2010 Oct; 14(4):383-6. PubMed ID: 20955272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure.
    Davenport A; Will EJ; Davison AM
    Nephrol Dial Transplant; 1989; 4(9):800-4. PubMed ID: 2516612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.